We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-4.76%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$1.85B
AUM Growth
-$19.7M
Cap. Flow
+$132M
Cap. Flow %
7.14%
Top 10 Hldgs %
47.07%
Holding
109
New
9
Increased
32
Reduced
9
Closed
22

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$72.1M
2
CMG icon
Chipotle Mexican Grill
CMG
+$39.8M
3
AMZN icon
Amazon
AMZN
+$39.1M
4
AMD icon
Advanced Micro Devices
AMD
+$35.4M
5
RPRX icon
Royalty Pharma
RPRX
+$31.1M

Top Sells

Rank Stock Value
1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$67.2M
2
XYZ
Block Inc
XYZ
+$28.8M
3
TSM icon
TSMC
TSM
+$23.9M
4
ACN icon
Accenture
ACN
+$21.6M
5
CP icon
Canadian Pacific Kansas City
CP
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 62.92%
2 Consumer Discretionary 12.25%
3 Technology 11.13%
4 Communication Services 4.55%
5 Industrials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$26.1B
$111M 6.01%
4,095,745
+1,048,696
+34% +$31.1M
BHVN icon
2
Biohaven
BHVN
$2.16B
$104M 5.63%
4,005,600
+138,042
+4% +$2.87M
ACLX
3
DELISTED
Arcellx
ACLX
$103M 5.56%
2,869,967
+21,800
+0.8% +$752K
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$91M 4.92%
786,313
-7,042
-0.9% -$757K
INSM icon
5
Insmed
INSM
$23.2B
$87M 4.7%
3,446,334
+337,000
+11% +$7.71M
META icon
6
Meta Platforms (Facebook)
META
$1.51T
$84.3M 4.55%
280,645
+29,415
+12% +$8.86M
AMZN icon
7
Amazon
AMZN
$2.5T
$78.7M 4.26%
619,469
+291,556
+89% +$39.1M
AMD icon
8
Advanced Micro Devices
AMD
$851B
$71.6M 3.87%
696,510
+325,903
+88% +$35.4M
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$71.4M 3.86%
1,369,849
+170,878
+14% +$9.96M
MSFT icon
10
Microsoft
MSFT
$2.84T
$68.9M 3.72%
+218,170
New +$72.1M
KURA icon
11
Kura Oncology
KURA
$922M
$66.9M 3.62%
7,335,845
+307,403
+4% +$3.12M
WYNN icon
12
Wynn Resorts
WYNN
$10.1B
$42.5M 2.3%
460,048
+161,390
+54% +$16.2M
MRNS
13
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$41.9M 2.26%
5,204,942
+1,147,331
+28% +$9.54M
ETNB
14
DELISTED
89bio
ETNB
$41.6M 2.25%
2,694,404
+301,168
+13% +$5.06M
GE icon
15
GE Aerospace
GE
$367B
$38.8M 2.1%
439,764
+198,268
+82% +$17.8M
NVDA icon
16
NVIDIA
NVDA
$5.01T
$38.5M 2.08%
885,480
+110,560
+14% +$4.95M
CMG icon
17
Chipotle Mexican Grill
CMG
$40.8B
$37.4M 2.02%
+1,020,000
New +$39.8M
GPN icon
18
Global Payments
GPN
$22.1B
$32.8M 1.77%
284,488
+3,300
+1% +$393K
TERN
19
DELISTED
Terns Pharmaceuticals
TERN
$30.4M 1.64%
6,041,910
+480,075
+9% +$3.05M
COGT icon
20
Cogent Biosciences
COGT
$6.79B
$29.8M 1.61%
3,053,300
+833,607
+38% +$9.89M
LVS icon
21
Las Vegas Sands
LVS
$30.5B
$29.5M 1.59%
642,833
-42,400
-6% -$2.29M
EYPT icon
22
EyePoint Inc
EYPT
$1.02B
$27.9M 1.51%
3,492,147
+68,250
+2% +$748K
ORCL icon
23
Oracle
ORCL
$331B
$27M 1.46%
255,311
-63,114
-20% -$7.31M
FULC icon
24
Fulcrum Therapeutics
FULC
$248M
$25.4M 1.37%
5,718,881
– –
RARE icon
25
Ultragenyx Pharmaceutical
RARE
$2.65B
$24.2M 1.31%
679,459
+137,979
+25% +$5.47M
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return

Suvretta Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Suvretta Capital Management held 109 positions worth $1.85B, down 1.1% from $1.87B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Suvretta Capital Management deployed $132M of net new capital in Q3 2023, opening 9 new positions and adding to 32 existing holdings. Its largest new stake was Microsoft: 218,170 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 61% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Oracle, an estimated $7.31M trimmed.

  • Suvretta Capital Management's largest Q3 2023 buy was Microsoft: 218,170 shares worth $68.9M.
  • Suvretta Capital Management added most to Amazon in Q3 2023, an estimated $39.1M increase.
  • Suvretta Capital Management's biggest Q3 2023 reduction was Oracle, cutting an estimated $7.31M.
  • Suvretta Capital Management fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $67.2M.
  • Suvretta Capital Management's ten largest holdings make up 47% of its $1.85B portfolio in Q3 2023.
  • Suvretta Capital Management opened 9 new positions and closed 22 in Q3 2023.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $1.85B.

Based on Suvretta Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.